The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

NCT01187238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Nasopharyngeal Carcinoma

Interventions

DRUG: cisplatin

Sponsor

Chinese Academy of Medical Sciences